{"disease":{"id":"ebola-virus-infection","name":"ebola virus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05284097","title":"Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT02363322","title":"Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04250168","title":"Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response","phase":"","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}